INTERNATIONAL: Global Round-up - News in brief

NEW YORK: Ketchum has won a PR brief for Novartis'

yet-to-be-branded arthritis treatment. The agency beat Hill & Knowlton

and Chamberlain Communications Group for the account to handle all

communications in the US for the COX189 through the drug's launch. The

drug is expected to become available in 2003.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.